Science Matters: Glimmers Of Hope For Treating ALS
Data And Developments In ALS Research
Recent clinical data using antisense drugs in neurological diseases are encouraging signs that targeting genetic drivers of ALS with antisense oligonucleotides or other gene-altering drugs could halt progression of several forms of the disease.
